Recently, H. W. Cheng, et al. [21] declared that CCL19-expressing fibroblastic stromal cells (FSCs) accelerated the intratumoral accumulation of CD8+ T cells and inhibited the tumor growth in non-small cell lung cancer. This evidence concerns the gene CCL19 and non-small cell lung carcinoma.